Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin.

Yang ZhaoMinKe HeRunBin LiangQiJiong LiMing Shi

Published in: Therapeutics and clinical risk management (2021)

Aprepitant, dolasetron plus dexamethasone is more effective to prevent chemotherapy-induced nausea and vomiting in hepatocellular carcinoma patients treated with FOLFOX-HAIC therapy than dolasetron plus dexamethasone.

Keyphrases

chemotherapy induced
low dose
high dose
squamous cell carcinoma
radiation therapy
cell therapy